Medical Devices

Please click on each product below to find out more information on our medical devices 

Citra-Lock™ S (trisodium citrate): Anticoagulant and Antimicrobial catheter lock solution to help maintain catheter patency and reduce catheter related infections. The range of pre-filled syringes contain trisodium citrate locking solution available in 4%, 30% & 46.7%.

Dexell® (positively charged diethylaminoethanol dextranomer microspheres) is a bulking agent indicated for the endoscopic treatment of vesicoureteral reflux (VUR) in children and stress urinary incontinence (SUI).

Dexell® (positively charged diethylaminoethanol dextranomer microspheres) consists of positively charged diethylaminoethanol (DEAE) dextranomer microspheres (active ingredient) suspended in a cross linked hyaluronic acid gel solution (transporter). Both the dextranomer microspheres and hyaluronate gel are biocompatible, non-immunogenic and bio-degradable.

Hyacyst® (sodium hyaluronate) is a bladder instillation indicated for the temporary replenishment of the GAG layer in the following bladder conditions; interstitial cystitis (IC), painful bladder syndrome (PBS), haemorrhagic cystitis, recurrent bacterial cystitis, radiation induced cystitis and chemotherapy induced cystitis.

Hyacyst® (sodium hyaluronate) is available in strengths of 40mg/50ml and 120mg/50ml which are supplied as Pre-Filled Syringes (PFS) or Vials. Hyacyst® PFS packs include a catheter adaptor to enable Hyacyst® PFS to be used with a wide variety of available catheters, making them suitable for self-instillation at home.

Hyacyst® (sodium hyaluronate) is approved for prescribing in the Community on FP10 prescriptions in the UK.

Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380
Subscribe to RSS - Medical Devices

Leave us a message

CONTACT US

International headquarters
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com